Invention Grant
- Patent Title: Anti-Siglec-15 antibody
-
Application No.: US14731519Application Date: 2015-06-05
-
Publication No.: US09751944B2Publication Date: 2017-09-05
- Inventor: Yoshiharu Hiruma , Eisuke Tsuda , Takeshi Takizawa , Makiko Nakayama
- Applicant: Daiichi Sankyo Company, Limited
- Applicant Address: JP Tokyo
- Assignee: Daiichi Sankyo Company, Limited
- Current Assignee: Daiichi Sankyo Company, Limited
- Current Assignee Address: JP Tokyo
- Agency: Foley & Lardner LLP
- Priority: JP2009-094613 20090409
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/395 ; C07K16/28 ; A61K45/06
Abstract:
Provided is a pharmaceutical composition for treating and/or preventing abnormal bone metabolism targeting a protein encoded by a gene strongly expressed in osteoclasts. Specifically provided is a pharmaceutical composition containing an antibody which specifically recognizes human Siglec-15 and has an activity of inhibiting osteoclast formation, and the like.
Public/Granted literature
- US20150299318A1 ANTI-SIGLEC-15 ANTIBODY Public/Granted day:2015-10-22
Information query
